Yes, phospholipid antibodies and antiphospholipid antibodies are the same thing.
The terms "phospholipid antibodies" and "antiphospholipid antibodies" (aPL) are interchangeable and refer to the identical group of autoantibodies. Both terms describe autoantibodies directed against phospholipids and/or phospholipid-binding proteins 1.
Terminology Clarification
The medical literature and current guidelines consistently use "antiphospholipid antibodies" (abbreviated as aPL) as the standard terminology 1. This is simply the more formal and complete way of saying "phospholipid antibodies"—the "anti-" prefix explicitly indicates these are antibodies against phospholipids.
What These Antibodies Include
When clinicians or laboratories refer to either term, they are describing the same family of autoantibodies that encompasses 1:
- Lupus anticoagulant (LA) - detected by clotting assays
- Anticardiolipin antibodies (aCL) - measured by ELISA
- Anti-beta2-glycoprotein I antibodies (aβ2GPI) - measured by ELISA
- Other related antibodies like antiphosphatidylserine/prothrombin antibodies
Clinical Context
These antibodies target phospholipid surfaces and phospholipid-binding proteins, driving the pathophysiology of antiphospholipid syndrome (APS)—a thrombo-inflammatory disease associated with thrombosis, pregnancy morbidity, and other autoimmune manifestations 1, 2.
Common Pitfall to Avoid
Don't confuse the terminology variation as indicating different antibodies or different tests. Whether a report says "phospholipid antibodies" or "antiphospholipid antibodies," the laboratory is measuring the same entities using the same standardized assays per the 2023 ACR/EULAR criteria and 2025 ISTH guidance 1.